Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, March 26, 2018
[ Mon, Mar 26th 2018
] - WOPRAI
[ Mon, Mar 26th 2018
] - WOPRAI
[ Mon, Mar 26th 2018
] - WOPRAI
[ Mon, Mar 26th 2018
] - WOPRAI
[ Mon, Mar 26th 2018
] - WOPRAI
[ Mon, Mar 26th 2018
] - WOPRAI
[ Mon, Mar 26th 2018
] - WOPRAI
[ Mon, Mar 26th 2018
] - WOPRAI
Fri, March 23, 2018
[ Fri, Mar 23rd 2018
] - WOPRAI
[ Fri, Mar 23rd 2018
] - WOPRAI
[ Fri, Mar 23rd 2018
] - WOPRAI
[ Fri, Mar 23rd 2018
] - WOPRAI
[ Fri, Mar 23rd 2018
] - WOPRAI
[ Fri, Mar 23rd 2018
] - WOPRAI
[ Fri, Mar 23rd 2018
] - WOPRAI
[ Fri, Mar 23rd 2018
] - WOPRAI
[ Fri, Mar 23rd 2018
] - WOPRAI
[ Fri, Mar 23rd 2018
] - WOPRAI
[ Fri, Mar 23rd 2018
] - WOPRAI
Anupam Rama Maintained (APLS) at Buy with Increased Target to $35 on, Mar 23rd, 2018
Anupam Rama of JP Morgan, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Buy with Increased Target from $31 to $35 on, Mar 23rd, 2018.
Anupam has made no other calls on APLS in the last 4 months.
There are 2 other peers that have a rating on APLS. Out of the 2 peers that are also analyzing APLS, 0 agree with Anupam's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Anupam
- Madhu Kumar of "B. Riley Securities" Initiated at Strong Buy and Held Target at $27 on, Thursday, February 8th, 2018
- Yigal Nochomovitz of "Citigroup" Initiated at Strong Buy and Held Target at $23 on, Monday, December 4th, 2017
